Also, bacterial antibodies differ from viral antibodies in a number of ways, and bacterial titer testing is typically done in veterinary medicine as a means of diagnosing acute illness, not
monitoring vaccine response or ongoing immunity.
Not exact matches
Janardan Pandey, Ph.D., an immunogeneticist specializing in immunoglobulin GM genes at the Medical University of South Carolina, helped
monitor for immune
responses that could limit the effectiveness of the broadly neutralizing antibody VRC01 in a phase 1 trial of that antibody in HIV - infected individuals led by a team at the
Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
Innovative imaging technologies to
monitor responses to
vaccines and infections in suitable models will provide information in characterisation of live
vaccine (such as BCG) of its biodistribution and persistence.
Specifically, 1 unit of access comprising a vaccination / challenge study with 3 groups of 6 ferrets (control and 2
vaccine groups), to include vaccination / boost, intra-nasal challenge with influenza virus,
monitoring of virus load (nasal washes), disease progression and immune
responses (antibody, IFN gamma ELISA and ELISpot).
He has made major contributions to
monitoring patients» immune
responses during
vaccine therapy and arriving at accurate prognoses.
Cancer
Vaccine Collaborative researchers Danila Valmori, Maha Ayyoub, Immanuel Luescher, and colleagues develop the first tetramer technology to
monitor CD4 T cell
responses to cancer vaccination.
We will evaluate the immunogenicity of
vaccine candidates (provided by user) administered by systemic, transdermal or mucosal routes and will
monitor humoral
responses and cellular
responses.
«The compassionate use of a VSVΔG - ZEBOV
vaccine in a case exposed to Ebola allowed very detailed
monitoring of the effects of this
vaccine on immune
responses and its side effects.
The unit of access comprises a vaccination / challenge study with 3 groups of 6 ferrets (control and 2
vaccine groups), to include intra-nasal challenge with influenza virus,
monitoring of virus load (nasal washes), disease progression and immune
responses (antibody, IFN gamma ELISA and ELISpot).